Gormsen, Lars C. http://orcid.org/0000-0001-6937-704X
Vendelbo, Mikkel H.
Pedersen, Mette Abildgaard
Haraldsen, Ate
Hjorthaug, Karin
Bogsrud, Trond Velde
Petersen, Lars J.
Jensen, Karen Juul
Brøndum, Rasmus
El-Galaly, Tarec C.
Article History
Received: 27 December 2018
Accepted: 12 April 2019
First Online: 3 May 2019
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Due to the retrospective nature of this study, the need for individual informed consent was waived. The Danish Ministry of Health approved the study (ref 3-3013-860/1/). The Danish Data Protection agency (ref 1-16-02-88-15) approved data collection.
: Not applicable.
: L.J.P has received grants from The Obel Family Foundation, he has received speaker’s fee from Bayer, Janssen, Astellas, Sanofi-Genzyme, and Janssen Pharma, and he has received consultancy fees from KLIFO Drug Development Council, Copenhagen, and ljpmedical, Aalborg, Denmark. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.